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The relation between acute 
changes in the systemic 
inflammatory response 
and circulating thiamine 
and magnesium concentrations 
after elective knee arthroplasty
Donogh Maguire1,6*, Anthony Catchpole2, Owen Sheerins3, Dinesh Talwar2, Alana Burns2, 
Mark Blyth3, Andrew Shaw3, Bryn Jones3, Colin Drury3, Johann Harten4, Innes Smith5 & 
Donald C. McMillan6
Thiamine diphosphate (TDP) and magnesium are co-factors for key enzymes in human intermediary 
metabolism. However, their role in the systemic inflammatory response (SIR) is not clear. Therefore, 
the aim of the present study was to examine the relation between acute changes in the SIR 
and thiamine and magnesium dependent enzyme activity in patients undergoing elective knee 
arthroplasty (a standard reproducible surgical injury in apparently healthy individuals). Patients 
(n = 35) who underwent elective total knee arthroplasty had venous blood samples collected pre- 
and post-operatively for 3 days, for measurement of whole blood TDP, serum and erythrocyte 
magnesium, erythrocyte transketolase activity (ETKA), lactate dehydrogenase (LDH), glucose and 
lactate concentrations. Pre-operatively, TDP concentrations, erythrocyte magnesium concentrations, 
ETKA and plasma glucose were within normal limits for all patients. In contrast, 5 patients (14%) 
had low serum magnesium concentrations (< 0.75 mmol/L). On post-operative day1, both TDP 
concentrations (p < 0.001) and basal ETKA (p < 0.05) increased and serum magnesium concentrations 
decreased (p < 0.001). Erythrocyte magnesium concentrations correlated with serum magnesium 
concentrations  (rs = 0.338, p < 0.05) and remained constant during SIR. Post-operatively 14 patients 
(40%) had low serum magnesium concentrations. On day1 serum magnesium concentrations were 
directly associated with LDH (p < 0.05), WCC (p < 0.05) and neutrophils (p < 0.01). Whole blood TDP 
and basal ETKA increased while serum magnesium concentrations decreased, indicating increased 
requirement for thiamine and magnesium dependent enzyme activity during SIR. Therefore, thiamine 
and magnesium represent potentially modifiable therapeutic targets that may modulate the host 
inflammatory response. Erythrocyte magnesium concentrations are likely to be reliable measures of 
status, whereas serum magnesium concentrations and whole blood TDP may not.
ClinicalTrials.gov: NCT03554668.
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In 2012, the National Research Council reported that dietary deficiency of vitamins and minerals affected > 80% 
of  Americans1,2. Similarly, the NHANES III study reported that multi-nutrient deficiencies were more prevalent 
in those with a BMI in the obese range than in the normal  population3,4.
Thiamine (vitamin B1) is an essential micronutrient that is required for optimal energy  metabolism5. A 
healthy adult human has approximately a 3-week reserve of thiamine in the body. However, these reserves may 
be rapidly depleted in times of sustained physiological stress (e.g. post-surgery or during systemic infection)6–11. 
Nonetheless, while it is recognised that plasma measurements of thiamine status may be perturbed by the sys-
temic inflammatory response, the direct measurement of thiamine diphosphate in red blood cells (erythrocytes) 
is known to reflect nutritional status and is not perturbed by the systemic inflammatory  response12–14.
It is of interest that thiamine requires magnesium for conversion to its active form, thiamine diphosphate 
(TDP)15, and TDP requires magnesium to act as a co-factor for thiamine dependent  enzymes5. Although this 
relationship has been well-understood biochemically for decades, the potential clinical relevance of such a rela-
tionship has received little attention to  date16,17.
Magnesium is the second most abundant intracellular cation, with approximately 99% of total body magne-
sium localized to the intracellular compartment in bone and soft tissue, and only approximately 1% localized in 
the  circulation18. There is an increasing awareness that magnesium plays an important role in energy  metabolism5, 
cardiovascular  health19, calcium  homeostasis20, oxidative resilience and genomic  stability21. Furthermore, low 
circulating magnesium concentrations have been implicated in increased prevalence of liver  disease22 and sig-
nificantly higher one year mortality among alcohol use disorder  patients23. Accurate quantification of total body 
magnesium is challenging, as magnesium is predominantly located within intra-cellular compartments, while 
circulating serum magnesium is approximately 30% bound to proteins (mainly albumin) and it is reported that 
free measurable magnesium may be perturbed by the inflammatory  response18.
There is now good evidence indicating that serum concentrations of other bivalent cations, including selenium 
and zinc, decrease transiently after a significant and reproducible inflammatory  insult24. These measurements, 
therefore, may not be reliable indicators of selenium or zinc status in the context of significant activation of the 
systemic inflammatory response. It is therefore of interest that the inter-relationship between thiamine status and 
magnesium status, and the effect of the systemic inflammatory response on serum magnesium concentrations 
and functional markers of thiamine status has not been well delineated to date.
Therefore, the aim of the present study was to examine the relation between acute changes in the systemic 
inflammatory response and thiamine and magnesium dependent enzyme activity in patients undergoing elec-
tive knee arthroplasty.
Patients and study design
The study protocol was approved by the East of England—Cambridgeshire and Hertfordshire Research Ethics 
Committee (17/EE/0270) and registered with clinicaltrials.gov (NCT03554668) (13/06/2018).
Patients who underwent elective primary total knee replacement surgery for osteoarthritis were consid-
ered eligible for study. Those patients with pre-operative CRP > 10 mg/L and reduced creatinine clearance 
(eGFR < 60 mL/ min/1.73  m2) prior to or following surgery were excluded from the study. In addition, patients 
who received thiamine/ magnesium supplementation during the study period were also excluded from the study.
Baseline demographic characteristics—including age, body mass index (BMI), and medical and drug history 
(including magnesium and thiamine supplementation), were recorded. Surgical procedures, tourniquet times, 
anesthetic methods and perioperative intravenous fluid therapy were also recorded. Venous blood samples were 
collected immediately before surgery and each morning after surgery for the next 3 days. Samples were collected 
between 0600 and 0800 following an overnight fast. Sample collection stopped if the patient was discharged or 
after day 3. Follow-up samples were taken 3 months post-surgery.
Standard serum separating tubes were used for routine serum biochemistry, EDTA tubes were used for both 
routine and whole blood thiamine diphosphate sample collection and study samples were collected in non-
gel lithium heparin tubes for measurement of ETKA and erythrocyte magnesium concentrations. All samples 
were conveyed to the laboratory within one hour of collection. Routine biochemistry and hematology samples 
were analyzed contemporaneously. Whole blood EDTA samples for thiamine diphosphate measurement were 
frozen at − 70 °C and analyzed within ten days of being drawn. Study samples for measurement of ETKA and 
erythrocyte magnesium were centrifuged (500G for 10 min), and plasma was carefully removed. Erythrocytes 
were washed three times prior to storage. Both the separated plasma and packed erythrocytes were stored at 
–70 °C until analysis. All samples from any given patient were assayed in a single batch for each of the analytes 
to minimize inter-batch analytic variation.
Routine ETKA measurement (in vitro TDP enhanced ETKA measurement) is a functional marker of thiamine 
status that measures the percentage change in ETKA when TDP is added to the assay, relative to basal ETKA. The 
percentage increase in transketolase activity following addition of TDP represents the patient’s thiamine status 
(> 15% and > 25% indicating moderate and severe thiamine deficiency respectively). This method of measure-
ment of thiamine status fell out of favor in the late 1990s, as it had been reported to be difficult to standardize, 
resulting in significant inter-laboratory variability. Routine ETKA measurement was superseded by the advent of 
high performance liquid chromatography (HPLC) that enabled reliable and direct measurement of TDP mass in 
whole blood  samples25,26. Nonetheless, some authorities observe that it is the functional activity of thiamine that 
is relevant rather than the finite mass  available6. For the present study, in addition to routine ETKA measurement 
(in vitro TDP enhanced ETKA measurement), pre- and post-operative basal ETKA has also been reported to 
examine the relative change of ETKA during the SIR.
The study was approved by the East of England—Cambridgeshire Research Ethics Committee and registered 
with clinicaltrials.gov (NCT03554668). All subjects were informed of the purpose and procedures of the study, 
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and all gave written consent. All procedures were conducted in accordance to the Declaration of Helsinki and 
conformed to NHS clinical research guidelines of Good Clinical Practice.
In the present study the sample size was based on our previous experience of the effect of elective surgical 
injury on measurements of micronutrients  status24. Based on other studies of a similar study design, the target 
number of patients required to obtain reliable statistical analysis was set at  3327.
Analytical methods. Measurement of thiamine diphosphate in whole blood involved HPLC isocratic sepa-
ration with post-column derivatization using sodium hydroxide and potassium ferricyanide and fluorescent 
detection. Results were expressed as nanogram of thiamine diphosphate per gram of hemoglobin (ng/gHb)28.
Erythrocyte transketolase (ETKA) was measured by adapting the method developed by Bayoumi and 
 Rosalki29. Briefly, ETKA was determined by a two-step coupled enzymatic reaction both with and without the 
in vitro addition of TDP (ETKA-TDP and basal ETKA respectively). The reduction of  NADP+ to NADPH was 
measured spectrophotometrically at 340 nm over 30 min to calculate ETKA in U/gHb. Hemoglobin for both 
thiamine diphosphate and ETKA methods were determined by the cyano-methemoglobin  assay30:
Erythrocyte magnesium was measured using inductively coupled plasma mass spectrometry on the Agilent 
7900 ORS-ICP-MS (Agilent Technologies, Santa Clara, California, United States). Erythrocyte magnesium was 
reported as mmol per gram of hemoglobin (mmol/gHb) to mitigate pipetting errors that are commonly associ-
ated with pipetting packed erythrocytes due to their  viscosity31. Hemoglobin concentration in the sample was 
derived using the 57Fe concentration and the above  equation31:
Serum C-reactive protein (CRP), albumin and magnesium were measured in accordance with the manufac-
turer’s instructions, by routine laboratory procedures, on an automated analyzer (Architect; Abbott Diagnostics, 
Abbott Park, Chicago, IL). For C-reactive protein, the limit of detection was 1 mg/L. The inter-assay CV was < 5% 
over the sample concentration range for the analytes measured.
In the present study the systemic inflammatory response is defined by the changes in tissue and organ function 
that accompany significant tissue injury, in particular acute phase  proteins32. This is in contrast to the changes 
defined in systemic inflammatory response  syndrome33.
Statistics. Data are presented as medians and inter-quartile ranges (IQR). Analysis of variance on all of the 
time period data were carried out by using Friedman’s test. When appropriate, comparisons of data from differ-
ent time periods were carried out by using Wilcoxon’s signed-rank test. The Mann–Whitney U test was used to 
test for significance between 2 independent samples. Correlations were carried out using Spearman’s rank cor-
relation  (rs). A p-value < 0.05 was considered to be  significant27. SPSS software (version 25, SPSS Inc, Chicago, 
IL) was used for the analysis.
Results
Patients (n = 47) who underwent elective primary knee arthroplasty for osteoarthritis were entered into the study. 
Two patients who received magnesium during the perioperative period were excluded from the analysis (n = 45). 
Eight patients (17%) had evidence of systemic inflammation (CRP > 10 mg/L) prior to surgery and were excluded 
from the analysis (n = 37). One of the subjects had reduced creatinine clearance (eGFR = 45 mL/ min/ 1.73  m2) 
prior to surgery and another patient had an eGFR < 60 mL/ min/ 1.73  m2 on day 1 post-surgery. Both of these 
patients were excluded from the analysis (n = 35). Of the remaining 35 patients, the majority were greater than 
65 years old (59%), female (54%) and obese (BMI ≥ 30 kg/m2; 74%).
Pre-operatively, whole blood thiamine diphosphate concentrations were above the lower limit of the refer-
ence interval (> 275 ng/gHb) for all patients. Five patients (14%) had serum magnesium concentrations below 
the lower limit of the reference interval (< 0.75 mmol/L) prior to surgery and one patient had an elevated serum 
lactate (2.4 mmol/L) (reference interval = 0.8–2.0 mmol/L). The relationship between baseline (pre-operative) 
whole blood thiamine diphosphate, serum and erythrocyte magnesium concentrations and clinicopathologi-
cal characteristics of patients who underwent elective surgery for primary total knee arthroplasty are shown 
in Table 1. There was no significant relationship between baseline serum magnesium concentrations and the 
clinicopathological characteristics. There were significantly higher median baseline erythrocyte magnesium 
concentrations in patients who had BMI-defined obesity (p < 0.01).
Prior to surgery whole blood TDP and TDP enhanced ETKA were classified above the lower reference interval 
and within normal limits for all patients (Fig. 1). This relationship remained similar during the post-operative 
systemic inflammatory response (Fig. 2).
Prior to surgery, 5 (14%) and 10 (29%) patients had serum and red cell magnesium values respectively below 
the lower reference interval (Fig. 3). On day 1 of the post-operative systemic inflammatory response, 14 patients 
(40%) had low serum magnesium concentrations (< 0.75 mmol/L) and 13 (37%) patients had red cell magnesium 
concentrations below the lower limit of the reference interval (< 6.5 mmol/gHb) (Fig. 4). Following surgery, 
serum magnesium concentrations changed significantly relative to pre-operative concentrations. In contrast, 
erythrocyte magnesium concentrations did not change significantly (Table 2).
Pre-operative erythrocyte magnesium concentrations correlated with serum magnesium concentrations 
 (rs = 0.338, p < 0.05) and this relationship remained constant on post-operative day 1  (rs = 0.392, p < 0.05).
In the immediate peri-operative period all patients received intravenous fluids intra-operatively and some 
received fluids to maintain hydration and intravenous access as required for routine clinical care. No patients 
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intravenous fluid administered in the first 24 h was 1000 mL (IQR: 875–1000 mL) and haematocrit remained 
within normal limits for all patients.
The pre- and post-operative measurements of thiamine diphosphate and magnesium dependent enzyme 
activity, basal ETKA, in patients undergoing elective knee arthroplasty surgery are shown in Table 2. Follow-
ing surgery, thiamine diphosphate concentrations (p < 0.001) and basal ETKA increased (p < 0.05) while serum 
magnesium concentrations decreased (p < 0.05) and reached their peaks and nadir respectively on day 1.
White cell count (p < 0.001), neutrophil count (p < 0.001), glucose (p < 0.001) and lactate (p ≤ 0.001) all 
increased with their peak on day 1. Lymphocyte (p < 0.001) and platelet counts (p < 0.001) fell with their nadir 
on day 1. CRP and albumin had their peak and nadir respectively on day 3 (both p < 0.001). The median peak 
C-reactive protein concentration of 178 mg/L on post-operative day 1 indicated a major surgical injury.
On day 1, whole blood thiamine diphosphate concentrations were directly associated with LDH  (rs = 0.435; 
p < 0.05), white cell count  (rs = 0.537; p < 0.01) and neutrophils  (rs = 0.518; p < 0.01). Serum magnesium con-
centrations were directly associated with LDH  (rs = 0.388; p < 0.05), WCC  (rs = 0.375; p < 0.05) and neutrophils 
 (rs = 0.367; p < 0.05). Plasma glucose was directly associated with plasma lactate  (rs = 0.575; p < 0.001).
Table 1.  The relationship between baseline thiamine and magnesium concentrations and clinicopathological 
characteristics of patients who underwent elective surgery for knee arthroplasty (n = 45). PPi’s proton pump 
inhibitors, OHA’s oral hypoglycaemic agents, CCB calcium channel blocker, ACEi angiotensin converting 
enzyme inhibitor, MTX methotrexate, BMI body masss index. Values are medians; IQR in parentheses. 
















No 18 519 (378–720) 0.79 (0.73–0.90) 6.9 (5.5–7.5)
Sex






F 25 552 (378–736) 0.81 (0.58–0.92) 6.9 (6.0–7.6)
BMI
 < 30 kg/m2






No 34 560 (413–736) 0.80 (0.58–0.92) 7.1 (5.5–7.8)
Smoker






No 37 546 (378–736) 0.81 (0.58–0.90) 6.8 (5.3–8.1)
Medications
PPi






No 19 521 (472–736) 0.79 (0.58–0.90) 7.0 (5.3–8.1)
OHA














No 44 549 (378–736) 0.81 (0.58–0.92) 6.8 (5.3–8.1)
Diuretics






No 36 524 (378–736) 0.80 (0.65–0.92) 7.0 (5.3–8.1)
CCB






No 28 523 (378–736) 0.80 (0.66–0.9) 6.8 (6.0–8.1)
ACEi






No 37 546 (378–736) 0.81 (0.58–0.92) 6.8 (5.3–8.1)
Statin






No 23 528 (378–714) 0.81 (0.58–0.90) 7.0 (5.5–8.1)
MTX






No 41 546 (378–729) 0.81 (0.58–0.92) 6.8 (5.3–8.1)
Sulphazalazine






No 43 546 (378–729) 0.81 (0.58–0.92) 6.8 (5.3–8.1)
Steroids






No 41 531 (378–736) 0.81 (0.58–0.92) 6.8 (5.3–8.1)
Supplements
Vitamin D






No 37 528 (378–736) 0.81 (0.58–0.92) 6.8 (5.3–8.1)
Vitamin B12






No 41 531 (378–736) 0.80 (0.58–0.90) 6.9 (5.3–8.1)
Folic acid






No 40 554 (378–736) 0.80 (0.58–0.92) 7.0 (5.3–8.1)
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At 3-month follow up, 23 patients had all biochemical tests repeated. All patients had whole blood thiamine 
diphosphate concentrations within normal limits and no significant difference was found relative to pre-operative 
base-line concentrations (p = 0.186). Only two of these patients had a low serum magnesium concentration 
pre-operatively and one remained low (0.70 mmol/L) at 3-month follow up. All patients reported a normal diet 
prior to and during their hospital stay and no patients reported taking nutritional supplements prior to or during 
the follow up period. No patients received any new medication that could have influenced serum magnesium 
Figure 1.  The relationship between pre-operative erythrocyte thiamine diphosphate and erythrocyte 
transketolase activation coefficient (ETK activation coefficient: erythrocyte transketolase activation coefficient).
Figure 2.  The relationship between day 1 post-operative erythrocyte thiamine diphosphate and erythrocyte 
transketolase activation coefficient (ETK activation coefficient: erythrocyte transketolase activation coefficient).
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Figure 3.  The relationship between pre-operative erythrocyte magnesium (mmol/gHb) and serum magnesium 
concentrations (mmol/L).
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concentrations during the post-operative period (e.g. diuretics). Patients who were taking oral hypoglycaemic 
medications or proton pump inhibitors prior to surgery continued taking these medications post-operatively.
Discussion
In the present study, prior to surgery whole blood TDP and ETKA were classified above the lower reference 
interval for all patients (Fig. 1) and this relationship remained similar during the post-operative systemic inflam-
matory response (Fig. 2). In contrast, prior to surgery serum and red cell magnesium variously classified patients 
below the lower reference interval (5 and 10 patients respectively, Fig. 3). This relationship further diverged dur-
ing the post-operative systemic inflammatory response (14 and 13 patients respectively, Fig. 4).
In the present study, whole blood TDP concentrations increased approximately 25% during the SIR. Hence, 
when interpreting whole blood TDP results in the context of the SIR, it may be that patients who have whole 
blood TDP concentrations in the lower quartile of the reference interval have had concentrations in the marginal 
deficiency range prior to evolution of SIR. Nonetheless, the standard functional test of thiamine status, in vitro 
TDP enhanced ETKA, is likely to be a reliable measure of thiamine status during the systemic inflammatory 
response as this did not demonstrate significant increase during the course of the SIR. This likely reflects the 
thiamine replete status of the patients recruited to the study. In contrast, basal ETKA increased significantly 
during evolution of the post-operative SIR. This in vivo enhancement of basal ETKA may reflect the increased 
mobilization of TDP reserves to meet the increased metabolic demands of the host inflammatory response.
Cook et al.observed in their review that it was the activity of thiamine that was relevant, rather than the finite 
mass  available6. Erythrocyte transketolase activity (ETKA) is a functional marker of thiamine dependent enzyme 
activity which was commonly used to measure thiamine status until the late 1990s, however this method of 
routine measurement of thiamine status fell out of favor due to difficulty with standardization, inter-laboratory 
variation and the advent of high performance liquid chromatography (HPLC), which enabled direct measure-
ment of thiamine diphosphate  mass25,26. Since > 90% circulating thiamine is present in erythrocytes in the form of 
activated thiamine diphosphate, direct measurement of thiamine status may be performed by measuring thiamine 
diphosphate concentration in either whole blood or packed red cells (erythrocytes)28,34. Direct measurement 
of erythrocyte and/or whole blood thiamine diphosphate concentrations also has the advantage of remaining 
consistent in the context of the systemic inflammatory  response13,14. Despite this, some authorities continue to 
recommend the measurement of baseline and TDP enhanced ETKA as the gold standard for the accurate quan-
tification of intracellular thiamine  status34,35. Interestingly, while ETKA is dependent on the presence of TDP, its 
activity may also be significantly influenced by circulating magnesium  concentrations36,37.
Low concentrations of thiamine diphosphate and/or magnesium may result in altered metabolism and 
increased lactate production (i.e. ‘a dirty burn’)5,38. Of note, the relationship between the systemic inflamma-
tory response, thiamine and lactate, has recently been highlighted by Marik et al. who reported a significant 
reduction in mortality among patients with confirmed sepsis who received a combination of thiamine, vitamin 
C and  hydrocortisone39. In their retrospective before-after clinical study, Marik et al. compared the mortality 
and clinical course of consecutive septic patients (n = 94) treated with intravenous thiamine, vitamin C and 
hydrocortisone (treatment group) with a control group treated in an intensive care unit (ICU) setting during 
a 7-month  period39. The primary outcome was hospital survival. There were 47 patients in each group with no 
significant differences in baseline characteristics reported between the two groups. Mortality was 8.5% 4of47 in 
Table 2.  Pre and post-operative measurements of thiamine and magnesium, dependent enzyme activity 
and intermediary metabolism in patients undergoing elective knee arthroplasty surgery (n = 35). Values are 
medians; IQR in parentheses. TDP thiamine diphosphate, CRP C-reactive protein, LDH lactate dehydrogenase, 
ETKA erythrocyte transketolase activity, Significant difference from pre-operative values calculated by 
Wilcoxon’s signed-rank test: *p ≤ 0.05, **p < 0.01, ***p < 0.001. 1 Friedman’s test.
Pre-operative Day 1 Day 2 Day 3
p-value1n = 35 n = 33 n = 32 n = 15
Whole blood TDP (275–675 ng/gHb) 528 (495–596) 671*** (617–726) 648*** (569–712) 613** (569–657)  < 0.001
Serum magnesium (0.75–1.0 mmol/L) 0.82 (0.78–0.86) 0.79*** (0.70–0.83) 0.78*** (0.73–0.82) 0.80* (0.74–0.83) 0.015
Erythrocyte magnesium (6.5–9.5 mmol/
gHb) 6.9 (6.4–7.4) 6.8 (6.2–7.5) 7.0 (6.4–7.5) 7.3 (6.4–7.6) 0.392
LDH (100–240U/L) 216 (178–234) 246*** (204–295) 218** (204–295) 236 (188–264) 0.241
ETKA (basal) (U/gHb) 0.41 (0.35–0.50) 0.47* (0.40–0.52) 0.46 (0.38–0.54) 0.47 (0.45–0.55) 0.423
ETKA (TDP enhanced) (U/gHb) 0.39 (0.28–0.46) 0.44 (0.38–0.49) 0.36 (0.27–0.46) 0.40 (0.31–0.48) 0.160
Glucose (4.1–7.0 mmol/L) 5.4 (5.1–6.1) 7.5*** (6.8–8.9) 6.6 *** (6.2–7.3) 6.6** (6.1–7.8)  < 0.001
Lactate (0.5–2.0 mmol/L) 1.0 (0.8–1.4) 1.8*** (1.3–2.2) 1.4** (1.0–1.8) 1.2 (0.9–1.5) 0.032
White cell count  (109/L) 6.8 (6.0–7.5) 12.3*** (10.9–14.1) 11.2*** (9.0 -12.5) 8.5*** (7.5–10.5)  < 0.001
Neutrophil count  (109/L) 4.2 (3.5–5.0) 9.8*** (8.1–11.2) 8.4*** (6.7–9.8) 6.6*** (5.1–7.8)  < 0.001
Lymphocyte count  (109/L) 1.7 (1.3–2.0) 1.1*** (0.9–1.7) 1.2*** (0.9–1.6) 1.1** (0.9–1.6) 0.001
Platelet count  (109/L) 245 (227–276) 218*** (203 -249) 202*** (181–230) 202*** (166–233)  < 0.001
CRP (< 10 mg/L) 3 (1- 6) 45*** (34–75) 167*** (123–259) 178*** (153–296)  < 0.001
Albumin (35–50 g/L) 41 (37–42) 35*** (33–37) 34*** (31–35) 30*** (29–34)  < 0.001
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the treatment group compared with 40.4% (19 of 47) in the control group (p < 0.001). As a result of Marik’s 
work, many emergency and critical care clinicians empirically administer thiamine and vitamin C to patients 
with SIRS and septic shock. To date, several RCT’s examining this hypothesis have reported variable results and 
the reason for this heterogeneity has not yet been  elucidated40. Given that magnesium is required for activation 
of free thiamine to active thiamine diphosphate within the cell and that thiamine dependent enzymes require 
magnesium for optimal activity, it is plausible that variability of baseline magnesium status may contribute to 
the variation in efficacy reported among patients treated with thiamine for SIRS and sepsis.
In the present study, such elective surgery offers the opportunity to examine how thiamine and magnesium 
concentrations are altered during the inflammatory response without the potential confounding of an underly-
ing disease state. Therefore, it is of considerable interest that serum magnesium concentrations significantly 
decreased by approximately 10% during the evolution of the systemic inflammatory response with the nadir on 
post-operative day 1. Although the percentage decrease in serum magnesium concentrations was small following 
surgery, the number of patients classified as having low serum magnesium concentrations (< 0.75 mmol/L) more 
than doubled 5vs14. In particular, patients in the lower quartile of pre-operative serum magnesium concentra-
tions were vulnerable to entering into the ‘low’ magnesium interval (0.70–0.74 mmol/L) and into the ‘very low’ 
serum magnesium interval (< 0.70 mmol/L) on day 1 of the post-operative SIR (see Figs. 3 and 4). It was also of 
interest that serum magnesium was inversely associated with WCC, neutrophil count and LDH on day 1 post-
operatively. Taken together these results may suggest that metabolic and immune responses are linked. Indeed, 
it has been proposed that nutrients and metabolites modulate inflammatory pathways and suboptimal nutrient 
concentrations may underlie many chronic disease  states41. Irrespective, these results may have implications for 
the moderation of the systemic inflammatory response.
Although circulating magnesium concentrations are tightly regulated, serum reference intervals remain a 
subject of controversy, as the original thresholds were described in a population that may have been  deficient18,42. 
Indeed, in the present study there was a weak correlation between serum and erythrocyte magnesium concentra-
tions at baseline and on day 1 (Figs. 3 and 4). Nevertheless, it is clear that low serum magnesium concentrations 
are consistently associated with poor survival in large epidemiological  studies21,22. Most epidemiological studies 
have defined concentrations below 0.70 mmol/l as “very low”18,19,43 whilst others have suggested concentrations 
below 0.75 mmol/l as “low”19,44. Furthermore, some evidence indicates that, in patients with critical illness, low 
circulating magnesium concentrations, based on serum measurements, are associated with higher mortality and 
it has been suggested that there is greater need for consideration of magnesium deficiency and its supplementa-
tion in patients in intensive  care38.
The recommended daily allowance (RDA) for magnesium is 320 mg and 420 mg for women and men 
 respectively45, and it has recently been reported from NHANES data that two thirds of North Americans may 
consume a diet that is magnesium deficient by between 65 and 220 mg/day depending on geographic region, 
while in Europe several epidemiologic studies have also shown that adults and children consuming a western 
type diet are consuming 30–50% of the RDA for  magnesium18,45–48. Low and very low circulating magnesium 
concentrations appear to be predominantly subclinical and therefore not routinely  investigated18,47,49.
Urinary retention of a magnesium diagnostic load may represent the gold standard for measurement of total 
body magnesium status, however this is cumbersome and may be of little pragmatic value in guiding clinicians in 
the acute  setting50. Therefore, measurement of erythrocyte magnesium concentrations may also provide valuable 
data regarding intracellular stores, however this test is not widely available at  present50,51. Overall, serum magne-
sium provides the most widely available and clinically useful assessment of an individual’s magnesium  status18.
Low magnesium concentrations, based on the serum measurement, have recently been reported to be asso-
ciated with numerous chronic diseases, including obesity, diabetes, cardiovascular disease, stroke, alcohol use 
disorder and cancer. The relationship between the systemic inflammatory response and serum magnesium 
concentrations in the context of these chronic disease states may therefore warrant further investigation.
Limitations. From the description of the clinicopathological characteristics of patients in the present study, 
it is clear that they may be a heterogenous group of patients. For example, 34 of the 45 patients were obese and 8 
of the 45 patients were current smokers. Nevertheless, this is, to our knowledge, the largest study of the relation-
ship between acute changes in the systemic inflammatory response and circulating thiamine and magnesium 
concentrations after elective knee arthroplasty. Moreover, neither obesity nor smoking appeared to impact on 
baseline serum concentrations of thiamine and magnesium.
Conclusion
White cell and neutrophil counts increased and lymphocyte counts decreased with their peaks and nadir on 
day 1 following elective knee arthroplasty. Plasma glucose and lactate concentrations and serum LDH activity 
also increased on post-operative day 1. Whole blood TDP concentrations and basal ETKA increased and serum 
magnesium concentrations decreased and reached their peaks and nadir respectively on post-operative day 1. 
Therefore, as co-factors and enzymes of intermediary metabolism change during the SIR, thiamine and magne-
sium represent potentially modifiable therapeutic targets that may modulate the host inflammatory response. 
Erythrocyte magnesium concentrations correlated with serum magnesium concentrations. Erythrocyte magne-
sium concentrations remained constant during the SIR and are likely to be reliable measures of status, whereas 
serum magnesium and whole blood TDP may not.
Data availability
Anonymized data will be made available upon reasonable request to the corresponding author.
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